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Hospitalization data typically cannot be used to estimate the num-
ber of individuals hospitalized annually because individuals are
not tracked over time and may be hospitalized multiple times an-
nually. We examined the impact of repeat hospitalizations on hos-
pitalization rates for various conditions and on comparison of rates
by diabetes status.
Methods
We analyzed hospitalization data for which repeat hospitalizations
could be distinguished among adults aged 18 or older from 12
states using the 2011 Agency for Healthcare Research and Qual-
ity’s State Inpatient Databases. The Behavioral Risk Factor Sur-
veillance System was used to estimate the number of adults with
and without diagnosed diabetes in each state (denominator). We
calculated percentage increases due to repeat hospitalizations in
rates and compared the ratio of diabetes with non-diabetes rates
while excluding and including repeat hospitalizations.
Results
Regardless of diabetes status, hospitalization rates were consider-
ably higher when repeat hospitalizations within a calendar year
were included. The magnitude of the differences varied by condi-
tion. Among adults with diabetes, rates ranged from 13.0% higher
for stroke to 41.6% higher for heart failure; for adults without dia-
betes, these rates ranged from 9.5% higher for stroke to 25.2%
higher for heart failure. Ratios of diabetes versus non-diabetes
rates were similar with and without repeat hospitalizations.
Conclusion
Hospitalization rates that include repeat hospitalizations overes-
timate rates in individuals, and this overestimation is especially
pronounced for some causes. However, the inclusion of repeat
hospitalizations for common diabetes-related causes had little im-
pact on rates by diabetes status.
Introduction
Hospitalization discharge data are often used to monitor diabetes-
related outcomes, such as amputation and heart attacks, and to
compare  the  risk  for  these  outcomes  among  adults  with  and
without diabetes (1–4). However, most hospital discharge data
sources do not provide the information needed to separate indi-
viduals from events (5,6). For this reason, annual hospitalization
rates are typically calculated by using the total number of hospital-
izations (including repeat hospitalizations) instead of the number
of individuals hospitalized (excluding repeat hospitalizations) in
the calendar year. Although the inclusion of repeat hospitaliza-
tions in rates may provide a measure of service utilization, their in-
clusion could bias estimates of disease incidence and complicate
analysis of disease trends, especially for chronic diseases.
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The purpose of our study was to examine the impact of repeat hos-
pitalizations on the magnitude of hospitalization rates for com-
mon diabetes-related outcomes or comorbidities and on the com-
parison of hospitalization rates for these causes by diabetes status.
Methods
We analyzed 2011 hospitalization data for adults aged 18 years or
older from the State Inpatient Databases (SID) of the Agency for
Healthcare Research and Quality (AHRQ) (7). SID contains in-
formation on inpatient discharges from hospitals in a given state,
regardless of payer. The participation of 48 states in SID enables it
to capture approximately 97% of all US community hospital dis-
charges. SID has more than 100 clinical and nonclinical variables,
including principal and secondary diagnoses and procedures, ad-
mission and discharge status, patient demographic characteristics,
expected payment source, total charges, and length of stay. A de-
tailed  description  of  the  data  are  available  at  www.hcup-
us.ahrq.gov/sidoverview.jsp.
We analyzed data only from 12 states (Arkansas, California, Flor-
ida, Hawaii, Iowa, Massachusetts, Mississippi, Nebraska, New
Mexico, New York, Vermont, and Washington) whose discharge
data distinguished repeat hospitalizations among individuals. The
hospitalization data in the 12 states provided synthetic identifica-
tion numbers (IDs) to link persons across events (ie, hospitaliza-
tions, emergency department visits,  and ambulatory surgeries).
The percentage of missing synthetic IDs for patients aged 18 to 64
was  2.1% for  Arizona,  11.7% for  California,  4% for  Florida,
30.9% for Iowa, 6.5% for Massachusetts, 7.6% for Mississippi,
none for Nebraska,  2.4% for New Mexico,  4% for New York,
7.3% for Utah, 13% for Vermont, and none for Washington (8).
The percentage missing synthetic IDs for patients aged 65 years or
older was less than 0.4% for Arizona, 2.6% for California, 1.2%
for Florida, 19.1% for Iowa, 2.3% for Massachusetts, 8.4% for
Mississippi, none for Nebraska, 2.5% for New Mexico, less than
0.5% for New York, 2.4% for Utah, 13.8% for Vermont, and none
for Washington (8).  For records missing IDs, we multiply im-
puted whether a case was a repeated hospitalization based on the
person’s age, sex, race/ethnicity, insurance, median income cat-
egory of residence zip code, and comorbidity score (9,10), using
fully conditional  specification methods.  A sensitivity analysis
showed no significant differences between estimates that used im-
puted data and estimates based on deleting missing data.
We excluded noncommunity or  rehabilitation hospitals  on the
basis of information from the American Hospital Association’s
Annual Survey Database. In our analyses, we defined repeat hos-
pitalizations as more than 1 hospitalization of the same person for
the same condition or discharge diagnosis, in a given calendar
year. This concept is different from that of readmission, which
typically uses a 30-day period and is used to examine quality of
care.
Hospitalization rates, with and without repeat hospitalizations for
selected causes, were calculated for people with and without dia-
betes. We used the first-listed discharge diagnosis code to identify
hospitalizations due to the following causes: major cardiovascular
disease (International Classification of Diseases, Clinical Modific-
ation,  9th  Revision  [ICD-9-CM] code  of  390–434,  436–448),
ischemic heart disease (ICD-9-CM code of 410–414,429.2), acute
myocardial  infarction  (ICD-9-CM code  of  410),  heart  failure
(ICD-9-CM code of 428), stroke (ICD-9-CM code of 430–434,
436–438), peripheral arterial disease (ICD-9-CM code of 250.7,
440.2, 442.3, 443.81, 443.89, 443.9, 444.22), and lower extremity
ulcer/inflammation (ICD-9-CM code of 454, 707.1, 680. 6–680.7,
681.1 ,  682.6–682.7 ,  711.05–711.07,  730.05–730.07,
730.15–730.17, 730.25–730.27, 730.35–730.37, 730.85–730.87,
730.95–730.97, 785.4). Lower extremity amputations were identi-
fied by using ICD-9-CM procedure code of 84.1 on the basis of all
listed procedures, excluding traumatic amputation based on dia-
gnosis code of 895–897 in any listed diagnosis. Among patients
with diabetes, we identified emergency department visits for hy-
poglycemia by using a first-listed diagnostic code of 251.0, 251.1,
251.2, or 962.3; or a first-listed diagnostic code of 250.8 that was
not accompanied by any of the following codes: 259.8, 272.7, 681,
682, 686.9, 707.1, 707.8, 707.9, 709.3, 730.0, 730.1, 730.2, or
731.8. Visits for hyperglycemic crisis were defined as those with
250.1 or 250.2 as the first-listed diagnosis. Discharges with any
diagnosis code for diabetes (ICD-9-CM 250.x) on any patient hos-
pitalization were considered diabetes-related.
To determine the number of patients with and without diabetes to
be used as the denominator for the calculation of hospitalization
rates, we used data from the 2011 Behavioral Risk Factor Surveil-
lance System (BRFSS). BRFSS is a collaborative project of the
Centers for Disease Control and Prevention (CDC) and US states
and territories that collects information on health behaviors and
conditions using state-based, ongoing, random-digit–dialed tele-
phone surveys of noninstitutionalized US civilian adults aged 18
or older (n = 144,433 for the 12 states). The median response rate
of all states in 2011 was 49.7% (11). The prevalence of diagnosed
diabetes was calculated as the percentage of the population an-
swering yes to the question “Have you ever been told by a doctor
that you have diabetes?” Women who had been told that they had
diabetes only during pregnancy and respondents told they had pre-
diabetes or borderline diabetes were not considered to have dia-
betes.
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We calculated rates of hospitalization (with and without repeat
hospitalizations) and calculated rate ratios by dividing rates for
diabetes by non-diabetic rates. All rates were age-adjusted to the
2000 US census population using age groups 18 to 44 years, 45 to
64 years, 65 to 74 years, and 75 years or older. Because hospitaliz-
ation data are a complete enumeration of events, we do not asso-
ciate any sampling error with them; the confidence intervals (CIs)
of the rates reflect the sampling error of the denominators derived
from BRFSS and the variance from multiple imputation. We ex-
amined the extent to which age-adjusted rates were overestimated
by calculating percentage increases in rates caused by including
repeat hospitalizations of individuals. The percentage increases in
rates simplify to a form that includes only complete counts of hos-
pitalizations and the variance induced by our multiple imputation
methods was so small that we ignored it; therefore, the variances
of percentage increases are zero.
All analyses were conducted by using SAS 9.1.3 (SAS Institute,
Inc) and SUDAAN 11.0.1 (RTI International) to account for the
complex sample designs of BRFSS. We used the delta method to
estimate the standard errors associated with hospitalization rates
and rate ratios (12).
Results
Our study included 10,384,306 hospital discharges from 12 states
in 2011. Regardless of diabetes status, repeat hospitalizations oc-
curred for all examined causes, although their impact on rates var-
ied by cause (Table). Compared with rates excluding repeats, rates
including repeat hospitalizations for adults with diabetes ranged
from 13.0% higher for stroke to 41.6% higher for heart failure; for
adults without diabetes, rates including repeats were 9.5% higher
for stroke to 25.2% higher for heart failure (Table). In general, for
each state (Appendix) and overall, increases in rates caused by in-
cluding repeat hospitalizations were higher for adults with dia-
betes than for those without diabetes. For heart failure and cardi-
ovascular disease, the increase in rates due to repeat hospitaliza-
tions were approximately 10 percentage points higher for patients
with diabetes compared with patients without diabetes. Hospitaliz-
ations due to hypoglycemia and hyperglycemic crisis, which are
specific to patients with diabetes, also increased hospitalization
rates when repeat hospitalizations were included. For hypogly-
cemia, the rate of increase was 9.9%, and for hyperglycemic crisis
it was 50.9%.
Regardless of cause of hospitalization, rates for adults with dia-
betes were considerably higher than rates for adults without dia-
betes (Table). Ratios of diabetes versus non-diabetes rates were
similar  regardless  of  whether  repeat  hospitalizations  were  in-
cluded.  Overall,  rate  ratios  including repeats  ranged from 2.9
(95% CI,  2.8–3.0)  for  stroke to  29.6  (95% CI,  28.0–31.1)  for
lower extremity amputation (Table). Rate ratios excluding repeats
ranged from 2.8 (95% CI, 2.7–3.0) for stroke to 27.4 (95% CI,
25.9–28.8) for lower extremity amputation. At the state level, rate
ratios that included and excluded repeat hospitalizations were also
similar (Appendix).
Discussion
Using hospitalization data from 12 states, this study demonstrated
that repeat hospitalizations for the same causes among individuals
within  a  calendar  year  are  common  in  populations  with  and
without diabetes and that repeat hospitalizations are more fre-
quent for some causes than others. Annual hospitalization rates in-
cluding repeat hospitalizations ranged from about 10% higher for
stroke to about 30% higher for heart failure in the total population,
compared with those not including repeat hospitalizations. This
finding suggests that hospital rates based on discharge data that in-
clude repeat hospitalizations may be considerably biased for es-
timating disease incidence. This is particularly true for conditions
with a high proportion of repeat hospitalizations such as hypergly-
cemic crisis,  for which inclusion of repeat hospitalizations in-
creased rates by approximately 50%. In addition, when such data
are used to examine trends, consideration should be given to the
possible impact of any change in frequency of repeat hospitaliza-
tions. For example, successful efforts to reduce 30-day readmis-
sion rates could reduce repeat hospitalizations without reducing
disease incidence rates among individuals.
Consistent with prior research indicating that adults with diabetes
are at excess risk of hospitalization from cardiovascular disease,
stroke,  and  lower  extremity  disease  (including  amputation)
(4,13–20), our study also found that adults with diabetes were sig-
nificantly more likely to be hospitalized for these conditions than
adults without diabetes, even after adjusting for age. Our results
also demonstrated that including repeat hospitalizations in the cal-
culation of rates had only a modest impact on rate comparisons of
populations with and without diabetes for common diabetes-re-
lated causes. For example, for acute myocardial infarction, the ra-
tio of diabetes to non-diabetes rates was 3.9 (95% CI, 3.7–4.0)
when  including  repeat  hospitalizations  versus  3.7  (95%  CI,
3.5–3.8) when excluding repeats. Thus, although hospitalization
rates of individuals were overestimated by including repeat hospit-
alizations, including them had little impact on the ratio of diabetes
to non-diabetes hospitalization rates for common diabetes-related
causes.
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This study had several limitations.  Because data from only 12
states were used to calculate hospitalization rates, our findings
may not be generalizable to the national population or any one re-
gion of the country. However, our findings on the impact of re-
peat hospitalizations on rates and rate ratios were, for the most
part, consistent across all 12 states, suggesting that the relation-
ships described may be robust, especially because the 12 states
evaluated were distributed across the country. A limitation of us-
ing administrative data, such as those from the SID, is the poten-
tial for inaccurate coding, and coding practices may vary across
hospitals and states. The extent to which diabetes status is misclas-
sified due to diabetes not being listed or incorrectly listed on dis-
charge abstracts is unknown. Finally, because BRFSS included
only noninstitutionalized people, our denominators for hospitaliza-
tion rates were underestimated for both the diabetic and non-dia-
betic populations. Hospitalization rates are overestimated for both
persons with and without diabetes because institutionalized people
were not included in the denominator but were included in the nu-
merator.
Surveillance practice commonly uses hospitalization data that in-
clude repeat hospitalizations among individuals to monitor the
burden of disease. To our knowledge, ours is the first study to
quantify the overestimation of hospitalization rates of individuals
for common diabetes-related causes due to the inclusion of repeat
hospitalizations and to determine whether this  in turns affects
comparisons of diabetes to non-diabetes rates. The results of this
study demonstrated that the use of repeat hospitalizations substan-
tially overestimated hospitalization rates for both the diabetic and
non-diabetic populations and that this overestimation varied by
cause. However, the inclusion of repeat hospitalizations for com-
mon diabetes-related causes had little impact on the comparison of
rates by diabetes status, suggesting that such surveillance data may
provide valid information on relative rates by diabetes status.
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Table










Yes 0.63 (0.60–0.65) 0.16 (0.16–0.16) 0.22 (0.22–0.22) 3.87 (3.73–4.02)
No 0.54 (0.52–0.56) 0.15 (0.14–0.15) 0.20 (0.19–0.20) 3.68 (3.54–3.82)
% Increase 16.02 10.20 12.52 —
Heart failure
Yes 1.14 (1.10–1.18) 0.21 (0.21–0.21) 0.34 (0.33–0.34) 5.45 (5.23–5.67)
No 0.81 (0.78–0.84) 0.17 (0.16–0.17) 0.26 (0.25–0.26) 4.82 (4.63–5.01)
% Increase 41.60 25.20 31.39 —
Cardiovascular disease
Yes 4.78 (4.61–4.96) 1.30 (1.29–1.32) 1.75 (1.73–1.77) 3.67 (3.53–3.81)
No 3.44 (3.32–3.57) 1.07 (1.05–1.08) 1.37 (1.35–1.39) 3.22 (3.10–3.35)
% Increase 38.98 22.07 27.63 —
Ischemic heart disease
Yes 1.41 (1.36–1.46) 0.33 (0.32–0.33) 0.47 (0.46–0.47) 4.29 (4.13–4.45)
No 1.15 (1.11–1.19) 0.29 (0.28–0.29) 0.40 (0.39–0.40) 4.01 (3.86–4.16)
% Increase 22.34 14.38 17.31 —
Stroke
Yes 0.65 (0.62–0.67) 0.22 (0.22–0.22) 0.28 (0.27–0.28) 2.93 (2.83–3.04)
No 0.57 (0.55–0.59) 0.20 (0.20–0.20) 0.25 (0.25–0.25) 2.84 (2.74–2.95)
% Increase 13.02 9.48 10.56 —
Lower extremity amputation
Yes 0.34 (0.33–0.36) 0.01 (0.01–0.01) 0.05 (0.05–0.05) 29.6 (28.03–31.10)
No 0.29 (0.28–0.31) 0.01 (0.01–0.01) 0.04 (0.04–0.04) 27.36 (25.94–28.78)
% Increase 18.04 9.24 16.45 —
Peripheral arterial disease
Yes 0.31 (0.30–0.33) 0.04 (0.04–0.04) 0.07 (0.07–0.07) 8.68 (8.35–9.01)
No 0.25 (0.24–0.26) 0.03 (0.03–0.03) 0.06 (0.06–0.06) 8.02 (7.71–8.32)
% Increase 24.93 15.37 21.55 —
Lower extremity ulcer
Yes 0.62 (0.59–0.66) 0.11 (0.11–0.12) 0.16 (0.16–0.16) 5.42 (5.11–5.72)
No 0.53 (0.50–0.56) 0.10 (0.10–0.10) 0.14 (0.14–0.14) 5.23 (4.93–5.52)
% Increase 17.31 13.20 14.46 —
Hypoglycemia
Yes 0.31 (0.29–0.32)  —  —  —
No 0.28 (0.26–0.29)  —  —  —
% Increase 9.93  —  — —
Hyperglycemic crisis
Yes 1.67 (1.50–1.84)  —  — —
No 1.11 (1.00–1.22)  —  — —
% Increase 50.85  —  — —
Abbreviations: —, does not apply; CI, confidence interval.
a Age-adjusted for adults aged 18–44, 45–64, 65–74, ≥75, based on the 2000 census.
b The 12 states are Arkansas, California, Florida, Hawaii, Iowa, Massachusetts, Mississippi, Nebraska, New Mexico, New York, Vermont, and Washington.
c Percentage increase is the increase due to including repeat hospitalizations.
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Appendix. Cause-Specific Hospitalization Rates With and Without Repeat
Hospitalizations Among Adults With and Without Diabetes for Selected Causes, by
State, 2011
This file is available for download as a Microsoft Word document at http://www.cdc.gov/pcd/issues/2015/docs/15_0274_Appendix.docx
[DOC – 51.0 KB].
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